Latest Regulatory Framework News

Sierra Nevada Gold (ASX – SNX) has won the bid for the expansive As Safra Copper-Gold Project in Saudi Arabia, marking a major step in its global exploration strategy. Concurrently, drilling progresses at its Nevada Warrior Gold Project with results anticipated soon.

Little Green Pharma reports record quarterly revenue and announces a transformative merger with Cannatrek, creating a leading vertically integrated medicinal cannabis group with strong European growth prospects.

EMC Gold has withdrawn its Salave Gold Project’s strategic interest application to strengthen future submissions, while raising €2.64 million from Spanish investors to advance engineering work.

KALiNA Power has strengthened its financial position by selling a 180 MW load allocation for C$18 million, while advancing its Alberta gas-fired power projects amid evolving regulatory frameworks.

MinRex Resources has obtained a crucial ASX waiver allowing it to issue shares to Electrum Discovery shareholders without needing further shareholder approval, smoothing the path for its planned acquisition.

Arovella Therapeutics has secured a crucial regulatory nod from the U.S. FDA, allowing its lead CAR-iNKT cell therapy, ALA-101, to enter first-in-human clinical trials targeting blood cancers.

Torque Metals is advancing its Paris Gold Camp project in Western Australia, moving from exploration to development readiness with a 250,000-ounce gold resource and an aggressive drilling program.

Key Petroleum Limited progresses its Potential Commercial Area applications in Queensland’s Cooper-Eromanga Basin, anticipating government approval by year-end, while planning a capital raise to bolster its limited cash reserves.

Gold Mountain Limited has reported promising assay results from its Irajuba Prospect in Brazil, revealing significant extensions to rare earth mineralisation and setting the stage for expanded resource drilling.

The ACCC has referred Ampol’s acquisition of EG Australia to a detailed Phase 2 review, citing concerns that the deal could significantly reduce competition in key Australian fuel markets.

Firebrick Pharma has introduced its Nasodine Throat Spray in Singapore, marking its first international product launch and setting the stage for further global rollouts in 2026.

Viking Mines reports promising high-grade tungsten oxide assay results from its Linka Tungsten Project in Nevada, reinforcing the project's potential amid soaring global scheelite prices.